DWA
CDLX icon

Dorsey Wright & Associates’s Cardlytics CDLX Stock Holding History

Dorsey Wright & Associates’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-41
Closed -$25K – 281
2019
Q4 		$25K Hold
41
– – 0.01% 118
2019
Q3 		$14K Buy
+41
New +$13.1K ﹤0.01% 159

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dorsey Wright & Associates's CDLX Position: Q1 2020 in Review

Dorsey Wright & Associates sold out of Cardlytics (CDLX) in Q1 2020, closing a stake of 41 shares — an estimated $25K sold.

Dorsey Wright & Associates first reported a position in CDLX in Q3 2019 and held it in 2 quarters. The position peaked at $25K in Q4 2019. 142 funds tracked by Wall St. Rank hold CDLX as of Q1 2020.

  • Dorsey Wright & Associates reported no remaining Cardlytics position as of Q1 2020 after selling out during the quarter.
  • Dorsey Wright & Associates sold 41 Cardlytics shares in Q1 2020, an estimated $25K.
  • Dorsey Wright & Associates first reported a position in Cardlytics in Q3 2019 and held it in 2 quarters.
  • Dorsey Wright & Associates's Cardlytics position peaked at $25K in Q4 2019.
  • 142 funds tracked by Wall St. Rank held Cardlytics as of Q1 2020.

Based on Dorsey Wright & Associates's 13F filing for Q1 2020, filed 20 Apr 2020.